Welcome to Welocalize Life Sciences’ Global Communicator.

As drug and therapy development continues to expand globally, pharma, biotech, and medical device companies need to incorporate techniques that transcend language, cultural, and geopolitical barriers. In this issue, get a preview of our upcoming webcast, “Optimizing Outcomes in Multinational Clinical Trials.” To engage more on the topic, meet our team at one of several events in February, including: DIA Europe, SCOPE, and DIA LATAM Regulatory.

The language focus for this issue is Russian. Find out which clinical documents that don’t require translation in the EU must be translated for trials taking place in Russia. We also share digital marketing tips for increasing patient engagement.

As always, thank you for reading Global Communicator. Please follow us on Twitter for daily updates related to the life science and language service industries.






Erin Wynn

Editor, Global Communicator
Chief Customer Officer, Welocalize Life Sciences